Probiotic supplementation attenuates increases in body mass and fat mass during high-fat diet in healthy young adults.
Study Goal
The researchers aimed to determine the effects of the probiotic VSL#3 on body and fat mass, insulin sensitivity, and skeletal muscle substrate oxidation in individuals consuming a high-fat diet.
Results Summary
VSL#3 supplementation reduced body mass and fat mass gain compared to placebo during a high-fat diet, but it did not significantly affect insulin sensitivity or skeletal muscle substrate oxidation.
Population
20 non-obese males aged 18-30 years.
Effective Dosage
Daily VSL#3 (specific dosage not mentioned).
Duration
4 weeks.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
VSL#3 | increase | body mass | non-obese males (18-30 years) | 1.42 ± 0.42 kg vs. 2.30 ± 0.28 kg | increased less | #1 |
VSL#3 | increase | fat mass | non-obese males (18-30 years) | 0.63 ± 0.09 kg vs. 1.29 ± 0.27 kg | increased less | #2 |
High-fat diet | no change | insulin sensitivity | non-obese males (18-30 years) | no significant change | no significant changes | #3 |
VSL#3 | no change | insulin sensitivity | non-obese males (18-30 years) | no significant change | no significant changes | #4 |
High-fat diet | no change | in vitro skeletal muscle pyruvate oxidation | non-obese males (18-30 years) | no significant change | no significant changes | #5 |
VSL#3 | no change | in vitro skeletal muscle pyruvate oxidation | non-obese males (18-30 years) | no significant change | no significant changes | #6 |
High-fat diet | no change | in vitro skeletal muscle fat oxidation | non-obese males (18-30 years) | no significant change | no significant changes | #7 |
VSL#3 | no change | in vitro skeletal muscle fat oxidation | non-obese males (18-30 years) | no significant change | no significant changes | #8 |
OBJECTIVE: The objective was to determine the effects of the probiotic, VSL#3, on body and fat mass, insulin sensitivity, and skeletal muscle substrate oxidation following 4 weeks of a high-fat diet. METHODS: Twenty non-obese males (18-30 years) participated in the study. Following a 2-week eucaloric control diet, participants underwent dual X-ray absorptiometry to determine body composition, an intravenous glucose tolerance test to determine insulin sensitivity, and a skeletal muscle biopsy for measurement of in vitro substrate oxidation. Subsequently, participants were randomized to receive either VSL#3 or placebo daily during 4 weeks of consuming a High-fat (55% fat), hypercaloric diet (+1,000 kcal day(-1) ). Participants repeated all measurements following the intervention. RESULTS: Body mass (1.42 ± 0.42 kg vs. 2.30 ± 0.28 kg) and fat mass (0.63 ± 0.09 kg vs. 1.29 ± 0.27 kg) increased less following the High-fat diet in the VSL#3 group compared with placebo. However, there were no significant changes in insulin sensitivity or in vitro skeletal muscle pyruvate and fat oxidation with the High-fat diet or VSL#3. CONCLUSIONS: VSL#3 supplementation appears to have provided some protection from body mass gain and fat accumulation in healthy young men consuming a High-fat and high-energy diet.